Asthma Digital Study
Completed · Not applicable
Conditions studied: Asthma
In brief
The Asthma Digital Study is a virtual, two-arm, randomized, controlled trial that will investigate the impact of digital tools on asthma symptom control, exacerbation frequency, healthcare utilization, and medical expenditures in adults with asthma.
Key facts
- Study ID
- NCT04609644
- Run by
- Elevance Health
- People needed
- 901
- Starts
- 2020-10-30
- Expected to finish
- 2023-11-04
- Last updated by the study team
- 2023-11-22
Who can join
Age: 18 and older, up to 64. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Health insurance coverage through an Anthem, Inc. affiliate.
- 18-64 years of age
- Resident of the United States for the duration of the study
- Comfortable reading and writing in English
- Owns an iPhone 6s or later
- Has been diagnosed with asthma by a provider
- 1+ emergency department visit in the preceding 24 months with an associated asthma diagnosis, or a combination of factors that might be associated with uncontrolled asthma. Factors include:
- History of asthma medication prescriptions
- History of asthma-associated primary care visits
- Diagnosis of chronic sinusitis, pharyngitis, influenza, allergic rhinitis, hypertension, diabetes, and/or obesity
- History of smoking
- Age and zip code
You may not qualify if…
- Unable to sleep in a bed with a Beddit sleep monitor at least 5 nights per week on average (e.g., shift workers who experience limited or erratic night-time sleep schedule, frequent travelers unable to stably sleep on the sensor at the requisite rate)
- Currently enrolled in any other asthma or pulmonary studies
- Currently on any immunologic for asthma
- Participated in a prior pilot study investigating the same digital tools
- Member of an Anthem plan with annual incentives limits of $100 or less
- Resident of Puerto Rico
- Pregnancy
- Diagnosis of any of the following:
- Chronic Obstructive Pulmonary Disease/Emphysema
- Cystic Fibrosis
- Any malignancy other than a non-melanoma skin cancer
- Any dementia diagnosis
- Neurodegenerative diseases (e.g., Parkinson's)
- Schizophrenia
- Heart failure
- On dialysis
- Women who are postpartum, with delivery in the past 8 weeks
Where it is running
- Jordan Silberman — Palo Alto, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.